Chronic Cough Market Size, Share, Analysis & Forecast by 2027

Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, Other and Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Geography

  • Report Code : TIPRE00011584
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

The chronic cough market is expected to reach US$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimated to grow at a CAGR of 7.8% from 2020 to 2027.

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupting sleep, creating vomiting sensation, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, and gastro esophageal reflux disease (GERD). The chronic cough market growth is attributed to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recalls is the major factor hindering the market growth.

Lucrative Regional Markets for Chronic Cough

Lucrative Regional Markets for Chronic Cough

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

MarketInsights

Rising Incidences of Chronic Cough

Chronic cough is caused due to asthma, acid reflux from the stomach,and postnasal drip. The conditions such as infection, bronchitis, and lung diseases are also likely to lead to chronic cough. The condition such as asthma is rising across the world; it is commonly seen among children and adults. Itis a major cause of the growing health burden in the US. For instance,according to the Centers for Disease Control and Prevention (CDC) data published in 2019, one among every three people has asthma in the US. Across America, over 25 million people live with asthma, which accounts for ~8% in adults, and nearly 8.5% in children.

In developing regions such as the Asia Pacific and the Middle East and Africa, the prevalence of chronic diseases is rising due to pollution and infections. The countries in these regions are highly populated. Although,cough is a non-communicable disease, it is increasing significantly in the countries. Several governments are putting their efforts to control the incidences of chronic cough in the respective countries. According to the National Health Policy 2017, India, premature mortality due to non-communicable diseases, including chronic cough, will be reduced by ~ 25% by 2025.

In the Middle East and Africa, respiratory diseases are rising due to climatic conditions. The countries surrounded by desserts are prone to the risk of respiratory diseases due to the easy spread of allergens. Over 60 to 70% of patients in the countries are diagnosed with respiratory diseases. Another major cause of chronic cough among people in the region is smoking. Nearly 30%of the people are addicted to smoking, which further leads to rising incidences of chronic cough.

Drug Class Insights

Based on drug class, the chronic cough market is segmented into antihistamines,contortionists, decongestants, combination drug, antibiotics, acid blockers,and other drug class. The combination drug segment held the largest share of the market in 2019 and the same segment is estimated to report the highest CAGR in the market during the forecast period. The growth of the segment is estimated due to benefits offered by the combination drugs such as the use of combination drugs can target treatment more than one symptom. Additionally, the combination of drugs is widely available as over the counter medicines.

Global Chronic Cough Market, by Drug Class – 2019 and 2027

Global Chronic Cough Market, by Drug Class – 2019 and 2027

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Route of Administration Insights

Based on rout of administration, the chronic cough market is segmented into oral, injections, inhalation, and other route of administration. The oral segment held the largest share of the market in 2019. However, the inhalation segment is estimated to register the highest CAGR in the market during the forecast period.

Distribution Channel Insights

Based on distribution channel, the chronic cough market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment held the largest share of the market in 2019. However, the online pharmacy segment is estimated to register the highest CAGR in the market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Chronic Cough Market: Strategic Insights

chronic-cough-market
Market Size Value inUS$ 5,430.0 Million in 2019
Market Size Value byUS$ 9,854.8 Million by 2027
Growth rateCAGR of 7.8% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Inorganic strategies are the more commonly adopted strategies by companies in the chronic cough market, which enables them expand their global footprints,and product and service portfolios. The market players have also adopted organic strategies such as product launches strategy to enlarge their global customer base, which also permits them to maintain their brand name globally.

Global Chronic Cough Market – By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Other Drug Class

Global Chronic Cough Market– By Route of Administration

  • Injections
  • Oral
  • Nasal
  • Other Route of Administration

Global Chronic Cough Market– By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Chronic Cough Market– By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America
    • Brazil
    • Argentina

Company Profiles

  • Novartis AG

  • Teva Pharmaceutical Industries Ltd
  • Glaxo SmithKline plc.
  • Bayer AG,
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Drug Class ; Route of Administration ; Distribution Channel ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is chronic cough?

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others.

What are the driving factors for the chronic cough market across the globe?

The growth of market is likely to grow due to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recall is the major factor hindering the market growth.

What is the average cost of chronic cough medicines?

The cost of chronic cough medicine starts from US$ 2 and above. The price of medicine depends upon the type of drug, whether it is tablet, syrup, or nasal spray. The generic and OTC drugs are much cheaper compared to the branded and prescribed ones.

The List of Companies - Chronic Cough Market

  1. Novartis AG
  2. Teva Pharmaceutical Industries Ltd
  3. Glaxo Smith Klineplc.
  4. Bayer AG
  5. Mylan N.V.
  6. Amneal Pharmaceuticals, Inc.
  7. Cipla Inc.
  8. Reckitt Benckiser Group plc.
  9. Sun Pharmaceutical Industries Ltd
  10. AurobindoPharma Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Chronic Cough Market